NCT04250259View on ClinicalTrials.gov

SAMe Trial for Patients With Alcoholic Cirrhosis

PHASE2RecruitingINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

October 22, 2020

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2027

Conditions
Alcoholic Cirrhosis
Interventions
DRUG

Placebo

2 tablets of placebo in the morning before breakfast and one tablet of placebo in the evening before dinner for 24 months

DRUG

SAMe 400 mg tablet

SAMe supplement (SAMe 400 mg tablet), 2 tablets in the morning before breakfast and one tablet in the evening before dinner (a total dose of 1,200 mg daily) for 24 months

Trial Locations (2)

46202

RECRUITING

Indiana University Hospital, Indianapolis

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
collaborator

Cedars-Sinai Medical Center

OTHER

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Indiana University

OTHER